Proposed Registration Decision PRD2022-18, Ipflufenoquin and Kinoprol 20 SC
This summary describes the key points of the evaluation, while the Science Evaluation of Proposed Registration Decision PRD2022-18, Ipflufenoquin and Kinoprol 20 SC provides detailed technical information on the human health, environmental and value assessments of ipflufenoquin and Kinoprol 20 SC.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
-
Proposed Registration Decision PRD2022-18, Ipflufenoquin and Kinoprol 20 SCHTMLEnglish publication HTML
-
Proposed Registration Decision PRD2022-18, Ipflufenoquin and Kinoprol 20 SCHTMLFrench publication HTML
Similar records